Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypes
Poller, Birk, Woessner, Ralph, Barve, Avantika, Tillmann, Hanns-Christian, Vemula, Janardhana, Nica, Alexandra, Elbast, Walid, Schiller, Hilmar, End, Peter, Camenisch, Gian, Weiss, MarkusJournal:
Pulmonary Pharmacology & Therapeutics
DOI:
10.1016/j.pupt.2019.101809
Date:
June, 2019
Fichier:
PDF, 1.07 MB
2019
File converter
Plus de résultats de recherche
More benefits 
